ATE407689T1 - Nachtkerzensamenextrakte als inhibitoren der zuckerabsorption und deren herstellungsprozess - Google Patents

Nachtkerzensamenextrakte als inhibitoren der zuckerabsorption und deren herstellungsprozess

Info

Publication number
ATE407689T1
ATE407689T1 AT01954345T AT01954345T ATE407689T1 AT E407689 T1 ATE407689 T1 AT E407689T1 AT 01954345 T AT01954345 T AT 01954345T AT 01954345 T AT01954345 T AT 01954345T AT E407689 T1 ATE407689 T1 AT E407689T1
Authority
AT
Austria
Prior art keywords
evening primrose
primrose seed
aforementioned
defatted
absorption inhibitor
Prior art date
Application number
AT01954345T
Other languages
English (en)
Inventor
Yotaro Konishi
Michio Aitani
Hiroshi Yamaguchi
Tsutomu Arimura
Tadashi Okada
Hiromichi Murai
Original Assignee
Oryza Oil & Fat Chem
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oryza Oil & Fat Chem filed Critical Oryza Oil & Fat Chem
Application granted granted Critical
Publication of ATE407689T1 publication Critical patent/ATE407689T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/60—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2
    • C07D311/62—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2 with oxygen atoms directly attached in position 3, e.g. anthocyanidins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Endocrinology (AREA)
  • Mycology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Fats And Perfumes (AREA)
  • Saccharide Compounds (AREA)
AT01954345T 2000-08-01 2001-07-26 Nachtkerzensamenextrakte als inhibitoren der zuckerabsorption und deren herstellungsprozess ATE407689T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000232930 2000-08-01

Publications (1)

Publication Number Publication Date
ATE407689T1 true ATE407689T1 (de) 2008-09-15

Family

ID=18725531

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01954345T ATE407689T1 (de) 2000-08-01 2001-07-26 Nachtkerzensamenextrakte als inhibitoren der zuckerabsorption und deren herstellungsprozess

Country Status (8)

Country Link
US (2) US6932990B2 (de)
EP (1) EP1312374B1 (de)
JP (1) JP4873824B2 (de)
CN (1) CN1268351C (de)
AT (1) ATE407689T1 (de)
AU (1) AU2001276682A1 (de)
DE (1) DE60135760D1 (de)
WO (1) WO2002009734A1 (de)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8563522B2 (en) * 1997-07-08 2013-10-22 The Iams Company Method of maintaining and/or attenuating a decline in quality of life
US20020035071A1 (en) * 1997-07-08 2002-03-21 Josef Pitha Mimicking the metabolic effects of caloric restriction by administration of glucose antimetabolites
US7713546B1 (en) 2001-04-03 2010-05-11 Soft Gel Technologies, Inc. Corosolic acid formulation and its application for weight-loss management and blood sugar balance
US7666459B2 (en) * 2001-09-12 2010-02-23 The Procter & Gamble Company Pet food compositions
KR20030075947A (ko) * 2002-03-19 2003-09-26 제네티카 주식회사 신 혈관형성을 억제하는 물질
EP1545554A4 (de) * 2002-07-24 2006-06-14 Univ Ohio Verfahren und zusammensetzungen zur behandlung von diabetes mellitus
JP4541662B2 (ja) * 2003-05-29 2010-09-08 オリザ油化株式会社 抗ピロリ菌組成物
GB0321996D0 (en) * 2003-09-19 2003-10-22 Novartis Nutrition Ag Organic compounds
JP2006335758A (ja) * 2003-10-06 2006-12-14 Oriza Yuka Kk ダイエット用組成物
ATE525080T1 (de) * 2003-10-06 2011-10-15 Oryza Oil & Fat Chem Dietätische zusammensetzung
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
EP1557094A1 (de) * 2004-01-26 2005-07-27 Wageningen Centre for Food Sciences Verbesserte halb-feste Lebensmittel und Methode zu ihrer Herstellung basierend auf der Inhibierung des von Amylasen induzierten Stärke Abbaus
US20050251265A1 (en) * 2004-05-07 2005-11-10 Calandruccio James H Trapezium implant for thumb and method
US20090252834A1 (en) * 2004-05-10 2009-10-08 Michael Griffin Hayek Compositions comprising glucose anti-metabolites
US20050249837A1 (en) * 2004-05-10 2005-11-10 The Procter & Gamble Company Processes for preparing plant matter extracts and pet food compositions
JP5112859B2 (ja) * 2004-06-04 2013-01-09 ホリズン サイエンス ピーティーワイ リミテッド 天然甘味料
JP5020462B2 (ja) * 2004-06-16 2012-09-05 クラシエフーズ株式会社 α−グルコシダーゼ阻害剤及びそれを用いた食品
JP2006016330A (ja) * 2004-06-30 2006-01-19 Suntory Ltd 脂肪燃焼促進剤
US20060051435A1 (en) * 2004-08-19 2006-03-09 Udell Ronald G Nutritional supplement for body fat reduction
JP2006056850A (ja) * 2004-08-23 2006-03-02 Suntory Ltd リパーゼ阻害剤
JP4772684B2 (ja) * 2004-08-30 2011-09-14 武田薬品工業株式会社 スクリーニング方法
JP2006104181A (ja) * 2004-09-13 2006-04-20 Takahiro Tsujita ブナ科植物由来の糖質分解酵素阻害物質、及びその用途
CN100566723C (zh) * 2004-09-13 2009-12-09 辻田隆广 衍生自壳斗植物的糖酶抑制剂及其应用
EP2261323A1 (de) 2005-05-31 2010-12-15 The Iams Company Probiotische Katzen-Laktobazillen
AU2006253007B2 (en) 2005-05-31 2012-12-20 Alimentary Health Ltd Feline probiotic Bifidobacteria
US8021697B2 (en) * 2005-06-03 2011-09-20 Horizon Science Pty. Ltd. Substances having body mass redistribution properties
US20070036874A1 (en) * 2005-08-05 2007-02-15 Litao Zhong Compositions and methods for controlling glucose and lipid uptake from foods
KR100829083B1 (ko) 2006-07-28 2008-05-16 재단법인 제주하이테크산업진흥원 생리활성을 갖는 애기달맞이 추출물
US9364016B2 (en) * 2006-09-19 2016-06-14 The Product Makers (Australia) Pty Ltd Extracts derived from sugar cane and a process for their manufacture
RU2436581C2 (ru) * 2007-02-01 2011-12-20 Дзе Иамс Компани Способ уменьшения воспаления и снижения стресса у млекопитающего
CN102036670A (zh) * 2007-02-01 2011-04-27 爱默思公司 用于减轻哺乳动物炎症和氧化应激反应的方法
WO2009137859A1 (en) 2008-05-15 2009-11-19 Alois Jungbauer Compounds for the treatment of metabolic syndrome and insulin resistance
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
PT2365988E (pt) * 2008-08-22 2015-10-22 Relypsa Inc Polímeros de permuta iónica reticulados, composições e uso no tratamento da hipercalemia
WO2010041702A1 (ja) * 2008-10-08 2010-04-15 株式会社 ポッカコーポレーション 抗鳥インフルエンザウイルス剤及び抗鳥インフルエンザウイルス剤含有製品
JP2010184909A (ja) * 2009-02-13 2010-08-26 Rheology Kino Shokuhin Kenkyusho:Kk 機能性組成物およびこの組成物を含有する医薬又は健康食品
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
CN102018766B (zh) 2009-09-16 2013-03-06 博仲盛景医药技术（北京）有限公司 一种植物提取物、其提取方法和用途及含有这种提取物的组合物
CN103561585B (zh) 2011-02-08 2016-05-25 产品制造者(澳大利亚)有限公司 糖提取物
RU2451506C1 (ru) * 2011-06-02 2012-05-27 Сергей Юрьевич Лешков Комбинация для лечения сахарного диабета и его осложнений
AU2013308395C1 (en) 2012-08-28 2018-03-15 Poly Gain Pte Ltd Extraction method
JP2014198684A (ja) * 2013-03-29 2014-10-23 サンスター株式会社 血糖代謝改善剤
AU2014306366B9 (en) 2013-08-16 2020-03-26 Poly Gain Pte Ltd Sugar cane derived extracts and methods of treatment
JP6998108B2 (ja) 2016-03-07 2022-01-18 株式会社ダイセル ウロリチン類を含有するα－グルコシダーゼ活性阻害剤、およびウロリチン類を含有する血糖値上昇抑制剤
JP7252904B2 (ja) * 2017-12-27 2023-04-05 サントリーホールディングス株式会社 腸管バリア機能改善用組成物
WO2022085602A1 (ja) * 2020-10-20 2022-04-28 サントリーホールディングス株式会社 Ｔｇｒ５活性化用組成物
JP2023035438A (ja) * 2021-09-01 2023-03-13 ビーエイチエヌ株式会社 血糖値上昇抑制剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3018013B2 (ja) * 1989-10-19 2000-03-13 三井農林株式会社 α―アミラーゼ活性阻害剤
JPH09176019A (ja) * 1995-12-26 1997-07-08 Suntory Ltd 糖質分解消化酵素阻害剤並びにこれを配合した医薬品および飲食品
DE69633502T2 (de) 1995-12-26 2006-02-23 Suntory Ltd. Procyanidin als den aktiven bestandteil enthaltende mittel gegen fettleibigkeit
AU9369198A (en) * 1998-09-30 2000-04-17 Industrial Research Limited Antioxidant compositions and process for their preparation

Also Published As

Publication number Publication date
EP1312374A1 (de) 2003-05-21
JP4873824B2 (ja) 2012-02-08
AU2001276682A1 (en) 2002-02-13
EP1312374A4 (de) 2004-04-21
DE60135760D1 (de) 2008-10-23
US6932990B2 (en) 2005-08-23
US20030161903A1 (en) 2003-08-28
CN1468106A (zh) 2004-01-14
WO2002009734A1 (en) 2002-02-07
EP1312374B1 (de) 2008-09-10
CN1268351C (zh) 2006-08-09
US20060024396A1 (en) 2006-02-02
WO2002009734A8 (en) 2002-02-28

Similar Documents

Publication Publication Date Title
ATE407689T1 (de) Nachtkerzensamenextrakte als inhibitoren der zuckerabsorption und deren herstellungsprozess
Oniszczuk et al. Extraction methods for the determination of phenolic compounds from Equisetum arvense L. herb
Ferreira et al. Antinociceptive effect from Ipomoea cairica extract
Pereira et al. Supercritical fluid extraction vs conventional extraction of myrtle leaves and berries: Comparison of antioxidant activity and identification of bioactive compounds
Rostagno et al. Pressurized liquid extraction of isoflavones from soybeans
Abd Ghafar et al. Antioxidant, α-glucosidase, and nitric oxide inhibitory activities of Phyllanthus acidus and LC–MS/MS profile of the active extract
Pacifico et al. Neuroprotective potential of Laurus nobilis antioxidant polyphenol-enriched leaf extracts
M’rabet et al. Profiling of phenolic compounds and antioxidant activity of Melia azedarach L. leaves and fruits at two stages of maturity
Susanti et al. Bioactive constituents from the leaves of Melastoma malabathricum L.
Costa et al. Copaifera langsdorffii supercritical fluid extraction: Chemical and functional characterization by LC/MS and in vitro assays
Díaz-de-Cerio et al. Establishment of pressurized-liquid extraction by response surface methodology approach coupled to HPLC-DAD-TOF-MS for the determination of phenolic compounds of myrtle leaves
Tung et al. Antioxidative phytochemicals from Rhododendron oldhamii Maxim. leaf extracts reduce serum uric acid levels in potassium oxonate-induced hyperuricemic mice
CA2633571A1 (en) Recovery of residual plant components after distillation of essential oils
Hosseini et al. Antioxidant effect of Achillea wilhelmsii extract on pentylenetetrazole (seizure model)-induced oxidative brain damage in Wistar rats
Pires et al. Qualitative and quantitative analysis of the phenolic content of Connarus var. angustifolius, Cecropia obtusa, Cecropia palmata and Mansoa alliacea based on HPLC-DAD and UHPLC-ESI-MS/MS
Sitthisak et al. Efficient extraction of quassinoids and alkaloids from Eurycoma longifolia Jack roots using natural deep eutectic solvents and microwave-assisted extraction
CA3043168C (en) Composition containing oroxylin a and method of extraction thereof
Zielińska-Pisklak et al. Activity-guided isolation, identification and quantification of biologically active isomeric compounds from folk medicinal plant Desmodium adscendens using high performance liquid chromatography with diode array detector, mass spectrometry and multidimentional nuclear magnetic resonance spectroscopy
Nugroho et al. Simultaneous analysis and peroxynitrite-scavenging activity of galloylated flavonoid glycosides and ellagic acid in Euphorbia supina
Alilou et al. Screening phytochimique et identification spectroscopique des flavonoïdes d’Asteriscusgraveolenssubsp. odorus
Abdel-Hameed et al. RP-HPLC-UV-ESI-MS phytochemical analysis of fruits of Conocarpus erectus L.
Barros et al. Antioxidant and hepatoprotective activities of Libidibia ferrea bark and fruit extracts
Batubara et al. The best extraction technique for kaempferol and quercetin isolation from guava leaves (Psidium guajava)
Raduan et al. Antioxidant capabilities of Litsea garciae bark extracts and their relation to the phytochemical compositions
EP1795201A1 (de) Isolierung von Oleuropein aus Blättern des Olivenbaums

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties